| Literature DB >> 20614002 |
Matthew A Malouf1, Arpana G Inman, Amanda G Carr, Jill Franco, Lindsey M Brooks.
Abstract
Little is known about the long-term health-related quality of life (HRQL) and mental health outcomes for women diagnosed with congenital adrenal hyperplasia (CAH), a disorder of sex development. Though recommendations for therapists exist, no research has empirically investigated women's experiences in therapy or their recommendations for therapy. Thus the purpose of the study was to investigate HRQL, mental health concerns of women with CAH, and patients' recommendations for therapists. A qualitative methodology, consensual qualitative research, was used to answer these questions. Eight women with CAH participated in the study. Results from their interviews revealed six domains: physical functioning, psychological functioning, interpersonal processes and relationships, healthcare experiences of women with CAH, recommendations for health care professionals, and systemic considerations. Domains were further broken down into categories with results yielding implications for both medical and mental health professionals and shedding light on issues related to normalcy, concerns both related and unrelated to CAH, sex, and gender, and highlighting effective supports and therapeutic interventions.Entities:
Year: 2010 PMID: 20614002 PMCID: PMC2896835 DOI: 10.1155/2010/253465
Source DB: PubMed Journal: Int J Pediatr Endocrinol ISSN: 1687-9848
Representation of cases within each category and subcategory across each domain.
| Domain/Category/Subcategory | Frequency* |
|---|---|
| Domain 1: Physical functioning | general |
| Normal functioning | general |
| (i) Able to function well with no or minimal CAH-related restrictions | typical |
| (ii) Normal functioning except for having to take medication daily | variant |
| Sexual functioning | general |
| Increased risk for sickness | general |
| Medication | general |
| (i) General medical regimens | typical |
| (ii) Stress dosing | typical |
| (iii) General side effects from medication | typical |
| (iv) Weight concerns from medication | typical |
| Physical side effects of CAH | typical |
| (i) Adrenal Crises and hospitalizations | typical |
| (ii) Reproductive functioning | variant |
| Domain 2: Psychological functioning | general |
| Processes involved in understanding or becoming aware of CAH | general |
| Understanding of identity | general |
| (i) Normal | variant |
| (ii) Different | variant |
| Emotions and cognitions related to CAH | general |
| (i) Negative | general |
| (ii) Positive | variant |
| Mental health concerns | typical |
| Sexuality | variant |
| (i) Gender identity and role | variant |
| (ii) Concentration and learning issues | variant |
| Domain 3: Interpersonal relationships and processes | general |
| Disclosure and others' awareness and knowledge of CAH | general |
| (i) Impact of CAH on others | general |
| (ii) Interaction of CAH's genetic component with relationships | general |
| (iii) Utilization of support groups | general |
| Supportive people and behaviors | general |
| (i) Parents | general |
| (ii) Other important relationships | general |
| (iii) Romantic Partners | typical |
| Unsupportive people and behaviors | typical |
| Impact of CAH on dating | typical |
| Having never met anyone else with CAH | typical |
| Domain 4: Healthcare experiences of women with CAH | General |
| Physicians | general |
| (i) Physician's knowledge of CAH | general |
| (ii) Negative medical interventions | general |
| (iii) Positive medical interventions | typical |
| (iv) Referrals | typical |
| Mental health clinicians: therapists, psychologists and psychiatrists | general |
| (i) Reasons for and goals of mental health treatment/therapy | general |
| (ii) Positive psychotherapeutic interventions | general |
| (iii) Negative psychotherapeutic interventions | variant |
| (iv) Clinicians' knowledge of CAH | variant |
| Intrapersonal processes in healthcare treatment | general |
| Domain 5: Recommendations for healthcare professionals | general |
| Helpful therapeutic traits | general |
| The need for more education about CAH | typical |
| (i) Things to consider when treating individuals with CAH | typical |
| (ii) Emotional impact | typical |
| Medical considerations | typical |
| Connect individuals with support groups | variant |
| The importance of access to therapeutic services | variant |
| Domain 6: Systemic considerations | general |
| Generational and cohort differences in women with CAH | typical |
| Availability and appropriateness of care | typical |
| Insurance and other financial concerns related to CAH | typical |
| Societal biases and expectations | variant |
*general = 7-8 cases, typical = 6 cases, variant = 2–5 cases.